Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: At $0.042, the current capitalization of PTSC is less then $17 million.

Unless we lose everything the current capitalization is way undervalued IMO... even if we have to wait awhile in order to start collecting licensing fees.

Share
New Message
Please login to post a reply